Ovarian cancer incidence in menopause

At present, the incidence of ovarian cancer accounts for gynecologic malignancies of 23% to 27%, to become the world's 5 largest high incidence of cancer mortality rate leapt to the top of the Gynecologic Oncology.

It can occur at any age for women, but many occurred in about half after menopause occurs after age 65.

Due to ovarian position deep in the pelvis, so early in the event of a cancer, patients can have no complaints, and therefore not to be noticed, but also not easy to take the initiative to carry out checks, often found already in advanced, treatment with considerable difficulties.

Therefore, patients with ovarian cancer survival rate of only 5 years of 30% to 50%. If women above the age of 30, especially before and after menopause, women can regular gynaecological and pelvic ultrasound scan, can be detected early, early diagnosis, and treatment in a timely and reasonable manner, then the ovarian cancer survival rate of 5 years to reach more than 90%.

Treatment of ovarian cancer is the principal means of surgical excision, postoperative chemotherapy is also very important, it should also be combined with immune therapy, radiation therapy, hormone treatment and medicine treatment, etc.

Patient treatment effect is good or bad and length of survival depends on tumor resection is thorough. Therefore, the operation should maximize tumor resection of the lesion. For those tiny tumors and invisible residual cancer cells must be taken after chemotherapy.

At present, many of the chemotherapy of ovarian cancer using postoperative, enough, many treatment method, which is to increase the cure rate and extended lifetime.

Due to ovarian cancer metastasis spread widely planted within the pelvic, therefore in order to give more exposure to cancer, ovarian cancer chemotherapy often use celiac drug delivery method. At present "taxol + Platinum-set" is used as a line of ovarian cancer chemotherapy standard programmes. Radiation therapy is the treatment of ovarian cancer a complementary therapy, primarily used for certain chemotherapy is not valid. Chinese medicine to enhance the body immunity patients with good effect. Immune therapy, gene therapy, although there are certain effects, but is not yet a large number of applications to the clinic.

(Practice editing: xiujie)